Medindia
Medindia LOGIN REGISTER
Advertisement

GFX: Wrinkle-Killer or Botox(R) Hit-Man?

Tuesday, March 11, 2008 General News
Advertisement
NORTH DALLAS, Texas and PLANO, Texas, March 10 Tired offrequent Botox injection visits? GFX might be the long-term wrinkle solutionfor you!

Newly-FDA approved GFX (Glabella Furrow Relaxation) recently arrived inNorth Texas and is already making waves -- radiofrequency waves, to be exact-- in select aesthetic centers and cosmetic surgery offices. GFX is a uniquetechnological advancement in facial rejuvenation that offers long-termrelaxation of overactive 'frown' muscles; a proposition likely to thrill manylong-time Botox users, but one that targets the Botox(R) empire for akill-shot where it would hurt the most ... right between the eyebrows.
Advertisement

Botox(R) muscle-relaxing injection results typically last from 3 to4 months on average, while the results of one in-office GFX (sometimes called'No-tox') treatment averages 18 months or longer. According to JeffreyAdelglass, M.D., F.A.C.S., a popular North Dallas area cosmetic surgeon whohas had plenty of experience working with a variety of cosmetic injectables,treatment of the glabella area alone constitutes approximately 65% -- thelion's share -- of his Botox injections. While his GFX patients might stillreceive periodic Botox(R) injections in other forehead areas (GFX is currentlyonly FDA-approved for the glabella), sometimes keeping the glabella relaxedcan, over time, soften wrinkles in other forehead areas, as well. An observedeffect of the treatment has been that eyebrows gradually tend to become moreelevated and horizontal forehead lines reduced, potentially eliminating theneed for elective surgery or neurotoxin injections entirely for some aestheticpatients.
Advertisement

How does GFX work? This minimally-invasive, in-office procedure utilizes aspecified dose of radiofrequency (RF) thermal energy, delivered through aninsulated bipolar needle inserted near the eyebrows, on either side of theforehead. First, the doctor delivers a stimulating pulse through the needle toidentify the appropriate motor nerve. Once the target is properly isolated, aradiofrequency burst reduces the nerve's functioning ability. The entire GFXprocedure takes about half an hour; results are immediate.

Dr. Adelglass is the Medical Director and Chief of Surgery for SKINTASTICMedical and Surgical Rejuvenation Center -- a medical spa located in the NorthDallas/Plano area. Dr. Adelglass was the first doctor to introduce GFXtechnology in North Texas. He performs the GFX treatment using IV sedation, apain management method with a superior safety record, which virtuallyeliminates any treatment discomfort. Dr. Adelglass cautions, however, that GFXshould only be administered by a physician who is extremely familiar with theinner-workings of the musculoskeletal and nerve branch anatomy and otherfacial structures. Because GFX results will be long-term or potentiallypermanent, selecting a qualified physician to administer the treatment isimportant.

Advanced Cosmetic Intervention, Inc. (ACI), the developers of GFXoriginally applied radiofrequency neuroablation technology in lifesavingcardiology treatments, later adapting it to its current aesthetic application.

The SKINTASTIC(TM) center in Plano, Texas (http://www.skintastic.com)focuses on providing the newest, most effective medical technologies andnon- to minimally-invasive cosmetic treatments, including chemical peels,dermal fillers (temporary to permanent), laser body sculpting, radiofrequency(RF) thermal skin tightening, permanent fat reduction, improvement ofcellulite, comprehensive nutrition, and various quick-recovery surgicaloptions. SKINTASTIC(TM) is currently providing complimentary evaluations forthose seeking information about the GFX, along with a variety of other skinresurfacing and aesthetic options that can prescribed alone, or incombination, for maximum cosmetic correction requiring minimal social downtimeand recovery.

Contact:

Pamela Fox,
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close